Blog - Page 3 of 33 - Metastatic Breast Cancer Trial Talk

Archives

FDA Approves Truqap

On November 16, 2023, the FDA approved capivasertib (Truqap™, AstraZeneca Pharmaceuticals) in combination with fulvestrant (Faslodex®) and a companion diagnostic...
Read More

SEARCH OUR SITE

for past articles or specific information.